Pharmamel
Drug discovery company focused on the therapeutic potential of melatonin and its analogues for neurological and oncological diseases. University of Granada spinoff.
About
Drug discovery company focused on the therapeutic potential of melatonin and its analogues for neurological and oncological diseases. University of Granada spinoff.
Details
- Funding
- €1.6M
- Founded
- 2014
- Website
- pharmameldrugdiscovery.com